In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, explains how the recently approved epinephrine nasal spray compares to the injectable products for treating anaphylaxis.
This is an excerpt from our October 2024 Pharmacy Essential Updates continuing education webinar series.
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools.
If you're a student, good news—students can access a free version of Pharmacist’s Letter.
Email us: ContactUs@trchealthcare.com.
The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
Learn more about our product offerings at trchealthcare.com.
